Physician profile
Myron Bell
NPI 1467443481
$1,950.99
in general payments reported to CMS, 2019-2025
17 companies · $89.75 in 2025
The $89.75 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $559 · 2021: $555 · 2023: $16.64 · 2025: $89.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $324.90 | 2019-2021 | |
| Abbott Laboratories | $308.25 | 2019-2023 | Amplatzer Talisman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.47 | 2019-2025 | Lifevest |
| Biotronik INC. | $143.44 | 2019 | |
| Pfizer INC. | $135.00 | 2019 | |
| Chiesi USA, INC. | $130.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $121.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.17 | 2019-2021 | |
| Boston Scientific Corporation | $106.87 | 2020-2025 | Solyx Sis System |
| Arbor Pharmaceuticals, INC. | $70.16 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $63.72 | 2020-2021 | |
| Amgen INC. | $56.39 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $46.65 | 2020-2021 | |
| Esperion Therapeutics, INC. | $35.19 | 2021 | |
| Philips North America LLC | $21.10 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.